Goldman Sachs Group (GS)

A market analyst has recommended Trent, Jio Financial Services, ABB, and Laurus Labs. He believes these stocks are poised for significant upside and offer attractive entry points shortly.

One analyst expects Mobileye's guidance updates to be more challenging due to the likely disruption caused by President Trump's trade policies.

The bank had an excellent quarter, despite a challenging environment.

The brokerage said that a "highly challenging environment" makes a near-term investment case for the auto sector "increasingly difficult.”

Futures point to a positive start when US equity markets open later this morning.

U.S. stock futures were volatile on Tuesday following a two-day advance. Futures of major benchmark indices were mixed in premarket.

Even a little bit of money invested in these three prospects will go a long way at their current valuations.

Goldman Sachs anticipates that ongoing macroeconomic volatility and consumer strain will act as a drag on the more "macro-sensitive segments,” such as hotels.

Goldman Sachs navigated volatility with record equity revenue in Q1 and warned of "material risks" to the economies amid the trade war.

Wall Street expects the lender to post earnings of $1.85 per share for the first quarter on revenue of $21.29 billion.

Morgan Stanley now estimates Apple's annualized tariff cost burden to be a much more "manageable" $7 billion, or just 5% of EBIT, versus the $44 billion estimates as of last Thursday.

Goldman Sachs Group posted strong Q1 2025 earnings, beating expectations in both EPS and revenue.

Goldman Sachs CEO David Solomon warned of uncertainty and potential turbulence ahead on the company's earnings call.

Goldman Sachs analyst Lizzie Dove downgrades U.S. Lodging C-Corps and Timeshares due to weaker consumer demand, geopolitical uncertainty, and negative impacts from U.S. airlines. The forecast for 2025 RevPAR is lowered by 125 basis points, with a 45% probability of a U.S. recession. Preference shifts towards asset-light companies with global exposure, focusing on non-RevPAR and ancillary revenues amid uncertain macro conditions.

It’s still all about trade but there are a few other things to watch this week.

Ironwood must run a new Phase 3 trial after FDA talks, delaying its SBS drug approval despite strong results from prior studies.

Goldman Sachs analyst Kate McShane shares insights on Dollar Tree and Home Depot, highlighting tariff impacts, valuation metrics, and inventory strategies.

Wall Street pared early morning gains by midday Monday, as investor caution returned despite a temporary easing in U.S.-China trade tensions. While the initial market reaction was positive, especially in tech, enthusiasm faded as the trading session progressed.

The sector needs to climb another 4% to fully recover its losses after Trump's April 2 tariff announcement.

Goldman Sachs (NYSE:GS) reported higher first-quarter results, with revenue of $15.06 billion beating expectations at $14.81 billion. Net interest income also rose. Global Banking & Markets saw a 10% increase in revenue, while Investment Banking fees declined 8%. The company also approved a $40 billion stock buyback program and declared a dividend of $3.00 per share.